Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses
Provides FDA with software tools to investigate drug-induced liver injury in clinical trials ... | April 18, 2023
Source: marketscreener.com
Page 22 - Simulations Plus News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Simulations Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Simulations Plus Today - Breaking & Trending Today
Bio Simulation Market Expected to Reach USD 8.99 Billion by 2030: Verified Market Research®
/PRNewswire/ -- The global Bio Simulation Market is projected to grow at a CAGR of 16.20% from 2023 to 2030, according to a new report published by Verified...
Source: prnewswire.com
Virtual Drug Design Promises Real Benefits
Computational drug design and cloud computing may increase success rates for drug candidates and decrease processing costs.
Source: genengnews.com
Simulations Plus, Inc. (NASDAQ:SLP) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Simulations Plus Second Quarter Fiscal 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com
Insider Selling: MongoDB, Inc. (NASDAQ:MDB) Director Sells $268,287.75 in Stock
Simulations Plus (NASDAQ:SLP – Get Rating) issued an update on its FY 2023 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.63-$0.67 for the period, compared to the consensus estimate of $0.65. The company issued revenue guidance of $59.30 million-$62.00 million, compared to the consensus revenue estimate of $60.79 […]
Source: dailypolitical.com